Introduction {#sec1}
============

The carbonyl functional group has a central role in modern organic synthesis because its vastly developed reactivity makes it very synthetically useful. Similarly, polycarbonylated compounds are valuable motifs. In particular, 1,3- and 1,4-dicarbonyl compounds are important building blocks in the synthesis of heterocycles.^[@ref1]^ 1,4-Dicarbonyl compounds are mainly employed in the synthesis of pyrroles,^[@ref2]^ furans,^[@ref3]^ and thiophenes^[@ref4]^ via the Paal--Knorr reaction ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}A--C). This framework is also present in diverse natural products and drugs, such as the cytotoxic diterpenoid maoecrystal V,^[@ref5]^ the anticancer drug batimastat,^[@ref6]^ and the antineoplastic food additive quassin^[@ref7]^ ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}D).

![Importance of 1,4-Dicarbonyl Compounds](ao0c00101_0001){#sch1}

Highly efficient strategies exist for achieving 1,3-dicarbonyl compounds, usually by exploiting the inherent polarity of the carbonyl group.^[@ref8]^ On the other hand, although several methodologies helpful in achieving different levels of complexity were developed to access 1,4-dicarbonyl compounds, they are often operationally difficult (e.g., by demanding anhydrous conditions), require multistep preparation of two starting materials, or even undergo undesired homoreactions. Most of these methodologies rely on the formation of a C--C bond via enolate alkylation,^[@ref9]^ NHC-catalyzed Stetter reaction,^[@cit3c],[@ref10]^ and oxidative coupling reactions.^[@ref11]^ A few examples of more straightforward strategies involving alkynes have been reported for the synthesis of 1,4-dicarbonyl compounds, including hydration of 3-alkynoates catalyzed by gold(III),^[@ref12]^ hydration of 3-en-1-ynes catalyzed by zinc(II) and gold(I) in the presence of Selectfluor,^[@ref13]^ hydration of alkynones catalyzed by palladium(II),^[@ref14]^ formal hydration of 4-alkynones mediated by KOMe,^[@ref15]^ and enantioselective formal dehydration of ynamides.^[@ref8]^

In this scenario, gold catalysis, which allows a rapid increase in molecular complexity from alkynes as starting materials,^[@ref16]^ is an outstanding alternative for accessing the carbonyl group because the addition of water to alkynes, when catalyzed by gold(I) and gold(III), is a mild, atom-economic, and operationally simple transformation.^[@ref17]^ However, gold-catalyzed hydration of internal alkynes suffers from a notable lack of regioselectivity.^[@ref18]^ In fact, to the best of our knowledge, no general method exists for achieving regioselectivity in hydration or hydroalkoxylation of internal alkynes by means of gold catalysis.^[@ref19]^ Reported strategies rely on the presence of electron-withdrawing groups^[@ref20]^ or, more frequently, on O- and N-based nucleophiles attached to the triple bond.^[@ref21]−[@ref23]^ These nucleophiles can act as directing groups that form cyclic cationic intermediates from intramolecular attack to the triple bond. Subsequently, water attacks a specific position on this intermediate, and the attached nucleophile becomes a leaving group. Because the formation of a cyclic intermediate is controlled by Baldwin's rules, ketones can be obtained with great regioselectivity. This strategy of using a carbonyl group as a neighboring nucleophile was first applied by Hammond and co-workers for the synthesis of γ-keto esters ([Scheme [2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"}A).^[@ref12]^ A similar strategy was used by Mohapatra and co-workers for the synthesis of γ-acetoxy β-keto esters ([Scheme [2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"}B).^[@ref24]^ The acetoxy group was claimed to be responsible for the observed selectivity.

![Strategies for Regioselective Au-Catalyzed Alkyne Hydration](ao0c00101_0002){#sch2}

We hypothesized that 1,4-enynes (**3**) prepared from Morita--Baylis--Hillman (MBH) adducts could readily furnish the access to a new pattern of highly functionalized 1,4,6-tricarbonyl compounds. We explored this possibility by exploiting the exceptional ability of cationic gold(I) complexes to activate triple C≡C bonds toward nucleophilic attack under mild conditions.^[@ref25]^ An electron-withdrawing fragment attached to the triple bond could differentiate the two C sp atoms favoring water attack at the distal carbon. Furthermore, the presence of an additional carbonyl group could speed up the reaction through anchimeric assistance. Should this assumption be correct, this strategy would allow rapid and high regioselective access to polyfunctionalized ketones ([Scheme [2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"}C).

Results and Discussion {#sec2}
======================

In order to test our hypothesis, we prepared MBH adducts **1** using a methodology previously developed by our group.^[@ref26]^ These adducts were then transformed into allylic bromides **2**. Most of these allylic bromides were prepared in good yields by treatment of MBH adducts with aqueous HBr solution in the presence of concentrated H~2~SO~4~.^[@ref27]^ However, under these conditions, we observed degradation of some starting materials. In these cases, Appel conditions furnished the desired allylic bromides.^[@ref28]^ Alkynylation of **2** with alkyl propiolates (**3a--c**) or but-3-yn-2-one (**3d**), in presence of 0.2 equiv of CuI and 1.0 equiv of K~2~CO~3~, led to enynes **4** in 44--88% yield ([Scheme [3](#sch3){ref-type="scheme"}](#sch3){ref-type="scheme"}).^[@ref29]^ The alkynylation conditions employed to prepare **4** were adapted from the methodology described by Kim and co-workers for the synthesis of substituted naphthalenes from allylic bromides in the presence of excess of base, through propargyl--allenyl isomerization of 1,4-enynes generated in situ. Unfortunately, the naphthalenes and the 1,4-enynes have the same *R*~*f*~ (on TLC plates) and could not be separated by column chromatography. We therefore avoided naphthalene formation by first reducing the original amount of the base (2.0 equiv) to 1.0 equiv. Under these conditions, enynes **4aa--da** and **4ae--ap** were obtained in typically good yields, at 60 °C. Enynes **4ab--ad**, bearing halogens in their aromatic moieties, could only be prepared at room temperature and only in moderate yields ([Scheme [3](#sch3){ref-type="scheme"}](#sch3){ref-type="scheme"}).

![Preparation of Substrates 1,4-Enynes (**3**)^,^\
Reaction conditions for the alkynylation step: ^a^MBH bromide **2** (1.0 mmol), **3** (1.2 equiv), copper iodide (0.2 equiv), potassium carbonate (1.0 equiv), and 10 mL of CH~3~CN (0.1 M). ^b^Isolated yields after column chromatography. ^c^Isolated yields based on recovery of the starting materials.](ao0c00101_0003){#sch3}

Once the substrates were prepared, enyne **4aa** was chosen as a model for optimizing the reaction conditions. The key results are summarized in [Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}.

###### Screening of Reaction Conditions[a](#t1fn1){ref-type="table-fn"}

![](ao0c00101_0008){#GRAPHIC-d7e358-autogenerated}

                                                                                                      conversion (%)[b](#t1fn2){ref-type="table-fn"}            
  ------------------------------------ ------------ ---------------------------------------- -------- ------------------------------------------------ -------- ----------
  1                                    C1 (5)       CH~3~CN/H~2~O (2/1)                      Rt       89 (83)[c](#t1fn3){ref-type="table-fn"}                    
  2                                    C1 (5)       CH~2~Cl~2~/H~2~O (2/1)                   Rt       83                                                         
  3                                    C1(5)        CH~3~CN/H~2~O (1/1)                      Rt       27                                                         
  4                                    C1(5)        CH~3~CN/H~2~O (1/2)                      Rt       29                                                         
  5                                    C2 (5)       CH~3~CN/H~2~O (2/1)                      Rt       94                                                         
  6                                    C3 (5)       CH~3~CN/H~2~O (2/1)                      Rt       95                                                         
  7                                    C4 (5)       CH~3~CN/H~2~O (2/1)                      Rt       94                                                         
  8                                    C5 (5)       CH~3~CN/H~2~O (2/1)                      Rt       94                                                         
  9                                    C6 (5)       CH~3~CN/H~2~O (2/1)                      Rt       82                                                         
  10                                   C7 (5)       CH~3~CN/H~2~O (2/1)                      Rt       76                                                         
  11                                   C2 (1)       CH~3~CN/H~2~O (2/1)                      Rt       50                                               79       92
  12                                   C2 (2)       CH~3~CN/H~2~O (2/1)                      Rt       53                                               79       94
  **13**                               **C2 (1)**   **CH**~**3**~**CN/H**~**2**~**O(2/1)**   **50**   **94**                                           **96**   **\>99**
  14                                   C2 (0.2)     CH~3~CN/H~2~O (2/1)                      50                                                                 21
  15[d](#t1fn4){ref-type="table-fn"}                CH~3~CN/H~2~O (2/1)                      50                                                                  

Reaction conditions: 0.2 mmol of **4aa**, in 1 mL of solvent (0.2 M), \[AgOTf\] = 2\[catalyst\].

Estimated by ^1^H NMR of the crude reaction mixture.

Isolated yields after column chromatography.

The reaction was carried out in the absence of gold catalyst, with 10 mol % of AgOTf, only 6% of conversion after 15 h.

We first ran the hydration of **4aa** in CH~3~CN/H~2~O (2/1, v/v) at room temperature, in the presence of 5 mol % of gold(I)-catalyst **C1** and 10 mol % of AgOTf. To our delight, under these conditions and just after 1 h, a conversion of 89% was observed ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entry 1). The expected product **5aa** was isolated in 83% yield as a single regioisomer. The structure of **5aa** was confirmed by ^1^H and ^13^C nuclear magnetic resonance (NMR) spectra as well as by high-resolution mass spectrometry (HRMS) analysis. Subsequently, CH~3~CN was replaced by CH~2~Cl~2~, keeping the initial proportion with water (2:1, v/v). Under these conditions, the conversion of **4aa** was reduced from 89% to 83% (entry 2). Because CH~3~CN furnished a better result, we moved toward investigating the proportion of solvents. Whereas **4aa** was converted at 89% with CH~3~CN/H~2~O (2:1, v/v), only 27% was achieved with CH~3~CN/H~2~O (1/1, v/v) (entry 3) and 29% with CH~3~CN/H~2~O (1:2, v/v) (entry 4), confirming CH~3~CN/H~2~O (2:1, v/v) as the most suitable solvent mixture for this transformation. We determined the best catalyst for this reaction by testing complexes **C2--C7**. Gold(I)-catalysts **C2--C4** and Au(III)-catalyst **C5** satisfactorily furnished conversions of 94--95% (entries 5--8). Conversely, the use of Au(III)-catalyst **C6** and Au(I)-catalyst **C7** yielded conversions of only 82 and 76%, respectively (entries 9 and 10). These results confirmed that this transformation was very smooth and fast; hence, we decided to investigate the possibility of reducing the catalyst loading. For this, we chose to use catalyst **C2**, based on its availability in our laboratory. Initially, the reaction was carried out using 1 mol % of **C2**; however, by 3 h, the conversion was poorer than in the previous conditions (entry 11). Similar results were observed with the use of 2 mol % of C2 (entry 12). In an attempt to improve the reactivity of **4aa**, the reaction temperature was increased to 50 °C. At this temperature, using 1 mol % of **C2**, full conversion (\>99%) of **4aa** was observed in 3 h (entry 13). An additional reduction of catalyst loading to 0.2 mol % led to a conversion of only 21% (entry 14). To rule out the possibility of silver-catalysis, we run the hydration of **4aa** in the presence of 10 mol % of AgOTf and in the absence of any gold catalyst. Under these conditions, a conversion of only 6% was observed after 15 h (Entry 15). Although a few examples of efficient silver(I)-catalyzed hydration of internal alkynes have been reported, they normally require harsh conditions (the use of strong acids or high temperatures).^[@ref30]^

Having established the optimized conditions ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entry 13), we evaluated the hydration scope. The 1,4-enynes containing aliphatic, styryl, heteroaryl, and halogenated aryl substituents at R^1^ position and 1,4-enynes with methyl ketone and different alkyl esters directly bonded to the triple bond (R^3^) were all found to be suitable substrates for this transformation, readily furnishing the hydrated product. Substrates containing R^2^ = OEt, OMe, and Me furnished corresponding poly-carbonylated compounds **5aa--an** in excellent yields (\>90%) and regioselectivities ([Scheme [4](#sch4){ref-type="scheme"}](#sch4){ref-type="scheme"}A). A different reactivity pattern was observed when enynes bearing a R^2^ = O^*t*^Bu were employed. To these enynes, the *tert*-butyl group was lost to form unexpected α-arylidene-butyrolactones **6a** and **6b**. Under the optimized hydration conditions, enyne **4ao** furnished cyclic enol ester **6a′** in excellent yields after filtration on a plug of Celite. However, when placed on silica, **6a′** was quantitatively converted into its endocyclic olefinic isomerized form **6a**. Similar behavior was observed with enyne **4ap**, although the exocyclic enolic double bond isomer could not be isolated with proper purity ([Scheme [4](#sch4){ref-type="scheme"}](#sch4){ref-type="scheme"}B).

![Substrate scope^,^\
Reaction conditions: **4** (0.1 mmol), Et~3~PAuCl (1.0 mol %), AgOTf (2.0 mol %) in CH~3~CN/H~2~O 2:1 (v/v) (0.5 mL), stirred at 50 °C for 3 h. ^b^Isolated yields after column chromatography. ^c^Isolated yield after filtration. ^d^Converted from **6a′** after column chromatography.](ao0c00101_0004){#sch4}

We then endeavored to gain further insights into the mechanism and influence of substituents on regioselectivity of the hydration reaction by preparing substrate **7** and performing a control experiment under our optimized conditions ([Scheme [5](#sch5){ref-type="scheme"}](#sch5){ref-type="scheme"}). Because **7** lacks one of the carbonyl moieties (the one that comes from the MBH adduct) that could work as a neighboring nucleophile, we were able to analyze the role of this carbonyl group on the rate of the hydration reaction and to determine whether the presence of the carbonyl group attached to the triple bond would be sufficient to provide selectivity on water attack, resulting in a regioselective hydration.

![Investigation of Carbonyl Moiety Effects on Regioselectivity and the Rate of the Hydration Reaction](ao0c00101_0005){#sch5}

Product **8** was obtained as a single regioisomer after 3 h. In agreement with our prediction, we verified that the reaction, in the absence of the carbonyl moiety coming from MBH adduct, required a higher catalytic loading for completion in 3 h (5 mol % of Et~3~PhAuCl), indicating that the reaction is slower for **7** than for the other substrates.

Based on the control experiment results and preliminary works,^[@ref12],[@ref21]^ we propose a plausible mechanism involving a cationic cyclic intermediate ([Scheme [6](#sch6){ref-type="scheme"}](#sch6){ref-type="scheme"}). First, gold(I) catalyst **C2** coordinates with triple bond of alkyne **4aa** leading to complex **A**. The activated alkyne moiety, in this complex, is then attacked by the nucleophilic carbonyl group, which is placed on the substrate to increase the rate of hydration, leading to cyclic vinyl gold intermediate **B** or **B′**, in which both favored processes according to Baldwin's rules. The **B′** type intermediate was proposed by Oh and co-workers in the regioselective hydration of 1-arylalkynes through carbonyl group participation.^[@cit21a]^ Because ketone **5aa′** was not observed, 5-*exo*-dig cyclization should be the preferential pathway because of the presence of an electron-withdrawing group attached at the triple bond. The intermediate **B** is, in sequence, attacked by water to form the ring-opened enol--gold species **D**, which undergoes protodeauration and leads to intermediate enol **E**. Finally, isomerization of **E** affords ketone **5aa** as a single product. This mechanistic proposal also accounts for the formation of **6a** and **6b**; upon nucleophilic attack of a water molecule, species **B″** furnishes a tetrahedral intermediate **C″**, which then loses ^*t*^BuOH to form the cyclic enol-gold ester **D''** ([Scheme [6](#sch6){ref-type="scheme"}](#sch6){ref-type="scheme"}, path a). Alternatively, species **D″** could be produced via direct formation of a *tert*-butyl cation ([Scheme [6](#sch6){ref-type="scheme"}](#sch6){ref-type="scheme"}, path b). Protodeauration of **D″** then generates **6a'**. To investigate these mechanistic proposals, we performed the reactions to form **5aa** and **6a′** using a 3:2 (v/v) mixture of H~2~O^[@ref16]^/H~2~O^[@ref18]^ under the optimized conditions. HRMS(ESI) analysis of **6a′** did not show any peak consistent with incorporation of O.^[@ref18]^ This result indicates that **6a′** is formed according to path b in [Scheme [6](#sch6){ref-type="scheme"}](#sch6){ref-type="scheme"}, with direct loss of a *tert*-butyl cation and no inclusion of water. On the other hand, HRMS (ESI) analysis of **5aa** showed the presence of a peak at *m*/*z* 329.1252, two mass units more than that found for the product hydrated by H~2~O.^[@ref16]^ Additionally, a quantitative NOE-decoupled ^13^C NMR experiment showed a new signal at δ = 167.3 ppm (see [Supporting Information](http://pubs.acs.org/doi/suppl/10.1021/acsomega.0c00101/suppl_file/ao0c00101_si_001.pdf)). Because this new signal is compatible with the chemical shift of a carboxyl carbon from an ester functional group and substantially different from the original ketone carbonyl signal (δ = 200.5 ppm), it is reasonable that the incorporation of O^[@ref18]^ happened in the α,β-unsaturated ester moiety. Finally, the integration of the new signal is about 40% of the carboxyl carbon of the α,β-unsaturated ester (proportional to the amount of H~2~O^[@ref18]^ used in the experiment). Besides supporting our mechanistic proposal of water attack on the cationic cyclic intermediate **B**, these results suggest that this is the only path in the reaction, without competition with a direct attack of water on the electrophilic alkyne carbon.

![Proposed Mechanism for the Au(I)-Catalyzed 1,4-Enyne Hydration](ao0c00101_0006){#sch6}

We demonstrated the synthetic importance of the polyfunctionalized ketones achieved in this work by preparing a set of biologically valuable^[@ref31]^ α-arylidene-γ-lactones **9a**--**g** in good yields through reduction of the corresponding ketones with sodium borohydride ([Scheme [7](#sch7){ref-type="scheme"}](#sch7){ref-type="scheme"}). Reduction of **5ah** led to a 5:1 inseparable mixture of α-alkylidene-γ-lactone **9g** and its endocyclic olefinic analogue **9g′** in 73% yield. Attempts to convert this mixture into the endocyclic regioisomer **9g′** as a single product by using rhodium(III)chloride hydrate^[@ref32]^ was unsuccessful.

![Synthesis of α-Alkylidene-γ-lactones from Tricarbonyl Compounds **5**\
Reaction conditions: **5** (0.1 mmol) and NaBH~4~ (1.2 equiv) in MeOH (1.3 mL), stirred at 0 °C for 30 min. ^b^**9g + 9g′** (0.1 mmol), RhCl~3~·3H~2~O (1 mol %) in EtOH at 80 °C.](ao0c00101_0007){#sch7}

Conclusions {#sec3}
===========

In summary, we have developed an efficient and highly regioselective gold(I)-catalyzed hydration of internal alkynes in a short reaction time and with low catalytic loading. The substrates, which were designed to provide regiocontrol and acceleration of the reaction, furnished polyfunctionalized ketones **5aa--ap** with a long carbon chain in excellent yields. The products are valuable intermediates in organic synthesis, as exemplified by the formation of lactones **9a--g** upon reduction. In the course of the scope development, we discovered that this methodology could also give the polyfunctionalized α-arylidene-β and γ-butenolides **6a** and **6b** in excellent yields.

Experimental Section {#sec4}
====================

General Information {#sec4.1}
-------------------

Unless otherwise noted, the commercially available reagents were used without any further purification. All experiments were monitored by thin-layer chromatography (TLC) on Merck silica gel 60 F254 precoated plates. The TLC plates were visualized under UV light (254 nm) or by exposure to sulfuric vanillin/dinitrophenylhydrazine/cerium molybdate stains, followed by brief heating with a heat gun. Purification by flash chromatography was performed on silica gel (230--400 mesh). NMR spectra were obtained in CDCl~3~ at 25 °C using 250/400/500/600 spectrometers. For ^1^H NMR spectra, the peak due to residual solvent (δ 7.26 ppm) was used as the internal reference. For proton-decoupled ^13^C NMR spectra, the reference was the central peak of the CDCl~3~ signal (δ 77.16 ppm). The data are reported as follows: chemical shift in ppm (relative to TMS), multiplicity (s = singlet, brs = broad singlet, d = doublet, t = triplet, q = quartet, m = multiplet, dd = doublet of doublets, ddd = doublet of doublet of doublets, and qd = quartet of doublets), coupling constants (*J*) in Hz, and integration. The absorption spectra in the infrared region (IR) were obtained with an Fourier transform infrared spectrophotometer fitted with a Ge crystal. The IR absorbance frequencies were expressed in cm^--1^. High resolution mass spectrometry (HRMS) was performed using electrospray ionization (ESI) (Synapt Q-TOF.). Melting points were measured and were not corrected. Compounds were named according to IUPAC rules using the MarvinSketch 15.9.21.0 program.

General Procedures for the Synthesis of Allylic Bromides **2a--l** {#sec4.2}
------------------------------------------------------------------

To a stirred solution of MBH adduct **1** in CH~2~Cl~2~ (0.1 M), at 0 °C, was added dropwise 48% aqueous HBr solution (6.0 equiv) and then concentrated aqueous H~2~SO~4~ solution (5.5 equiv). After stirring overnight at room temperature, the mixture was cooled to 0 °C and diluted with H~2~0. The aqueous phase was extracted with CH~2~Cl~2~ (3×), and the combined organic phase was washed with H~2~O. After removal of solvent under reduced pressure, the residue was purified by flash silica gel column chromatography using a mixture of ethyl acetate/hexane as eluent to afford the corresponding allylic bromide. The spectral data of known allylic bromides are the same as described.^[@ref25]^

General Procedures for the Synthesis of Allylic Bromides **2m--p** {#sec4.3}
------------------------------------------------------------------

To a stirred solution of MBH adduct **1** in dry CH~2~CI~2~ (0.1 M), PPh~3~ (2.0 equiv) and CBr~4~ (2.0 equiv) were added under a nitrogen atmosphere. The colored mixture was stirred at room temperature until TLC analysis showed complete consumption of the start material (1--2 h). After completion, the reaction mixture was quenched with cold water and extracted with CH~2~CI~2~ (3×). After removal of solvent under reduced pressure, the residue was purified by flash silica gel column chromatography using a mixture of ethyl acetate/hexane as eluent to afford the corresponding allylic bromide. The spectral data of known allylic bromides are the same as described.^[@ref26]^

### Ethyl (2Z)-2-(Bromomethyl)-3-(3,4,5-trimethoxyphenyl)prop-2-enoate (**2f**) {#sec4.3.1}

It was obtained as a pale yellow solid (73%): mp 64.5--66.1 °C. ^1^H NMR (500 MHz, CDCl~3~): δ 7.76 (s, 1H), 6.87 (s, 2H), 4.44 (s, 2H), 4.33 (q, *J* = 7.1 Hz, 2H), 3.91--3.90 (m, 9H), 1.38 (t, *J* = 7.1 Hz, 3H). ^13^C NMR (126 MHz, CDCl~3~): δ 166.2, 153.5 (2C), 143.2, 139.3, 129.8, 128.2, 107.2 (2C), 61.6, 61.1, 56.4 (2C), 27.7, 14.4. IR (ATR, ν~max~): 2956, 1713, 1253, 1122, 771. HRMS (ESI) *m*/*z* calcd for C~15~H~20~BrO~5~^+^ \[M + H\]^+^, 359.0489; found, 359.0463.

### (3*Z*)-3-(Bromomethyl)-4-(3,4,5-trimethoxyphenyl)but-3-en-2-one (**2m**) {#sec4.3.2}

It was obtained as a white solid (80%): mp 98.6--100.3 °C. ^1^H NMR (250 MHz, CDCl~3~): δ 7.59 (s, 1H), 6.92 (s, 2H), 4.40 (s, 2H), 3.92--3.91 (m, 9H), 2.50 (s, 3H). ^13^C NMR (63 MHz, CDCl~3~): δ 197.2, 153.6 (2C), 143.5, 139.5, 136.7, 129.7, 107.3 (2C), 61.1, 56.5 (2C), 26.1, 26.1. IR (ATR, ν~max~): 2937, 1662, 1331, 1126, 847. HRMS (ESI) *m*/*z* calcd for C~14~H~17~BrNaO~4~^+^ \[M + Na\]^+^, 351.0202; found, 351.0201.

### *tert*-Butyl (2*Z*)-2-(Bromomethyl)-3-phenylprop-2-enoate (**2n**) {#sec4.3.3}

It was obtained as pale yellow oil (62%): ^1^H NMR (250 MHz, CDCl~3~): δ 7.73 (s, 1H), 7.57--7.53 (m, 2H), 7.49--7.38 (m, 3H), 4.36 (s, 2H), 1.58 (s, 9H). ^13^C NMR (63 MHz, CDCl~3~): δ 165.4, 141.9, 134.7, 130.6, 129.6 (2C), 129.4, 129.0 (2C), 81.8, 28.2, 27.3. IR (ATR, ν~max~): 2970, 1704, 1365, 1138, 754, 700. HRMS (ESI) *m*/*z* calcd for C~14~H~17~BrNaO~2~^+^ \[M + Na\]^+^, 319.0304; found, 319.0321.

### *tert*-Butyl (2*Z*)-2-(Bromomethyl)-3-(4-methoxyphenyl)prop-2-enoate (**2o**) {#sec4.3.4}

It was obtained as yellow oil (98%): ^1^H NMR (250 MHz, CDCl~3~): δ 7.68 (s, 1H), 7.57--7.52 (m, 2H), 7.01--6.95 (m, 2H), 4.40 (s, 2H), 3.85 (s, 3H), 1.57 (s, 9H). ^13^C NMR (63 MHz, CDCl~3~): δ 165.7, 160.7, 141.9, 131.8 (2C), 128.2, 127.2, 114.5 (2C), 81.6, 55.5, 28.3, 28.0. IR (ATR, ν~max~): 2974, 1700, 1603, 1512, 1255, 1141. HRMS (ESI) *m*/*z* calcd for C~15~H~19~BrNaO~3~^+^ \[M + Na\]^+^, 327.0590; found, 327.0573.

General Procedure for the Synthesis of Enynes (**4aa--ap**) {#sec4.4}
-----------------------------------------------------------

The corresponding MBH bromide **2** (1.0 mmol), copper iodide (0.2 mmol, 0.2 equiv), and potassium carbonate (1.0 mmol, 1.0 equiv) were added in a round-bottom flask containing a stir bar. The flask was equipped with a rubber septum and was purged with nitrogen using a needle. Dry acetonitrile (10 mL) and appropriate terminal alkyne (1.2 equiv) were then added. The reaction was stirred under a nitrogen atmosphere at the optimized temperature. After 2 or 24 h, 15 mL of saturated aqueous ammonium chloride solution was added, and the resulting mixture was extracted at room temperature with ethyl acetate (3 × 15 mL). After removal of the solvent under reduced pressure, the residue was purified by flash silica gel column chromatography, using a gradient mixture of ethyl acetate/hexane as the eluent, to afford the corresponding enyne.

### 1,6-Diethyl (5*E*)-5-(Phenylmethylidene)hex-2-ynedioate (**4aa**) {#sec4.4.1}

It was obtained after 2 h at 60 °C, as colorless oil (73%): ^1^H NMR (400 MHz, CDCl~3~): δ 7.83 (s, 1H), 7.44--7.36 (m, 5H), 4.32 (q, *J* = 7.1 Hz, 2H), 4.21 (q, *J* = 7.1 Hz, 2H), 3.52 (s, 2H), 1.37 (t, *J* = 7.1 Hz, 3H), 1.30 (t, *J* = 7.1 Hz, 3H). ^13^C NMR (126 MHz, CDCl~3~): δ 166.6, 153.8, 141.8, 134.7, 129.5 (2C), 129.4, 128.9 (2C), 125.9, 86.0, 73.2, 62.0, 61.5, 18.3, 14.37, 14.1, 14.1. IR (ATR, ν~max~): 2982, 2235, 1704, 1246, 1201, 725. HRMS (ESI) *m*/*z* calcd for C~17~H~18~NaO~4~^+^ \[M + Na\]^+^, 309.1097; found, 309.1089.

### 6-Ethyl 1-Methyl (5*E*)-5-(phenylmethylidene)hex-2-ynedioate (**4ba**) {#sec4.4.2}

It was obtained after 2 h at 60 °C as colorless oil (75%): ^1^H NMR (400 MHz, CDCl~3~): δ 7.83 (s, 1H), 7.44--7.28 (m, 5H), 4.32 (q, *J* = 7.1 Hz, 2H), 3.75 (s, 3H), 3.52 (s, 2H), 1.37 (t, *J* = 7.1 Hz, 3H). ^13^C NMR (101 MHz, CDCl~3~): δ 166.6, 154.2, 141.9, 134.6, 129.5 (2C), 129.4, 128.9 (2C), 125.8, 86.5, 72.9, 61.5, 52.7, 18.3, 14.4. IR (ATR, ν~max~): 2982, 2235, 1704, 1247, 1201, 725. HRMS (ESI) *m*/*z* calcd for C~16~H~16~NaO~4~^+^ \[M + Na\]^+^, 295.0941; found, 295.0936.

### 1-*tert*-Butyl 6-Ethyl (5*E*)-5-(Phenylmethylidene)hex-2-ynedioate (**4ca**) {#sec4.4.3}

It was obtained after 2 h at 60 °C as colorless oil (68%): ^1^H NMR (250 MHz, CDCl~3~): δ 7.82 (s, 1H), 7.45--7.37 (m, 5H), 4.33 (q, *J* = 7.1 Hz, 2H), 3.49 (s, 2H), 1.49 (s, 9H), 1.37 (t, *J* = 7.1 Hz, 3H). ^13^C NMR (63 MHz, CDCl~3~): δ 166.7, 152.85, 141.7, 134.7, 129.6 (2C), 129.3, 128.8 (2C), 126.1, 83.5, 83.2, 74.5, 61.5, 28.1 (3C), 18.2, 14.4. IR (ATR, ν~max~): 2981, 2240, 1705, 1274, 768. HRMS (ESI) *m*/*z* calcd for C~19~H~22~NaO~4~^+^ \[M + Na\]^+^, 337.1410; found, 337.1437.

### Ethyl (2*E*)-6-Oxo-2-(phenylmethylidene)hept-4-ynoate (**4da**) {#sec4.4.4}

It was obtained after 2 h at 60 °C as colorless oil (47%): ^1^H NMR (250 MHz, CDCl~3~): δ 7.84 (s, 1H), 7.45--7.37 (m, 5H), 4.33 (q, *J* = 7.1 Hz, 2H), 3.56 (s, 2H), 2.31 (s, 3H), 1.37 (t, *J* = 7.1 Hz, 3H). ^13^C NMR (126 MHz, CDCl~3~): δ 184.7, 166.6, 141.7, 134.6, 129.4 (2C), 129.3, 128.8 (2C), 125.9, 90.5, 81.0, 61.4, 32.8, 18.4, 14.3. IR (ATR, ν~max~): 2983, 2210, 1708, 1676, 1222, 771. HRMS (ESI) *m*/*z* calcd for C~16~H~17~O~3~^+^ \[M + H\]^+^, 257.1172; found, 257.1157.

### 1,6-Diethyl (5*E*)-5-\[(4-Bromophenyl)methylidene\]hex-2-ynedioate (**4ab**) {#sec4.4.5}

It was obtained after 24 h at rt as a pale yellow solid (44%) (67% brsm): mp 73.0--75.0 °C. ^1^H NMR (500 MHz, CDCl~3~): δ 7.74 (s, 1H), 7.57--7.55 (2H, m), 7.31--7.30 (m, 2H), 4.31 (q, *J* = 7.1 Hz, 2H), 4.21 (q, *J* = 7.1 Hz, 2H), 3.48 (s, 2H), 1.36 (t, *J* = 7.1 Hz, 3H), 1.30 (t, *J* = 7.1 Hz, 3H). ^13^C NMR (126 MHz, CDCl~3~): δ 166.4, 153.7, 140.5, 135.5, 132.1 (2C), 131.0 (2C), 126.5, 123.8, 85.4, 73.5, 62.0, 61.7, 18.2, 14.3, 14.1. IR (ATR, ν~max~): 2982, 2231, 1696, 812, 752, 499. HRMS (ESI) *m*/*z* calcd for C~17~H~17~BrNaO~4~^+^ \[M + Na\]^+^, 387.0202; found, 387.0229.

### 1,6-Diethyl (5*E*)-5-\[(4-Chlorophenyl)methylidene\]hex-2-ynedioate (**4ac**) {#sec4.4.6}

It was obtained after 24 h at rt as a pale yellow solid (57%) (\>99% brsm): mp 59.0--61.0 °C. ^1^H NMR (500 MHz, CDCl~3~): δ 7.76 (s, 1H), 7.40--7.36 (m, 4H), 4.31 (q, *J* = 7.1 Hz, 2H), 4.21 (q, *J* = 7.1 Hz, 2H), 3.48 (s, 2H), 1.36 (t, *J* = 7.1 Hz, 3H), 1.29 (t, *J* = 7.1 Hz, 3H). ^13^C NMR (126 MHz, CDCl~3~): δ 166.3, 153.6, 140.4, 135.4, 133.0, 130.8 (2C), 129.1 (2C), 126.0, 85.4, 73.4, 62.0, 61.6, 18.1, 14.3, 14.1. IR (ATR, ν~max~): 2982, 2231, 1696, 1253, 813, 754. HRMS (ESI) *m*/*z* calcd for C~17~H~17~ClNaO~4~^+^ \[M + Na\]^+^, 343.0708; found, 343.0713.

### 1,6-Diethyl (5*E*)-5-\[(3-chlorophenyl)methylidene\]hex-2-ynedioate (**4ad**) {#sec4.4.7}

It was obtained after 24 h at rt as a pale yellow solid (52%): mp 50.5--52.7 °C ^1^H NMR (400 MHz, CDCl~3~): δ 7.75 (s, 1H), 7.40--7.32 (m, 4H), 4.31 (q, *J* = 7.1 Hz, 2H), 4.22 (q, *J* = 7.1 Hz, 2H), 3.49 (2H, s), 1.37 (t, *J* = 7.1 Hz, 3H), 1.30 (t, *J* = 7.1 Hz, 3H). ^13^C NMR (126 MHz, CDCl~3~): δ 166.3, 153.7, 140.2, 136.4, 134.9, 130.2, 129.5, 129.4, 127.4, 127.3, 85.4, 73.6, 62.1, 61.7, 18.2, 14.4, 14.1. IR (ATR, ν~max~): 2982, 2242, 1700, 1262, 797. HRMS (ESI) *m*/*z* calcd for C~17~H~17~ClNaO~4~^+^ \[M + Na\]^+^, 343.0708; found, 347.0729.

### 1,6-Diethyl (5*E*)-5-\[(4-Methoxyphenyl)methylidene\]hex-2-ynedioate (**4ae**) {#sec4.4.8}

It was obtained after 2 h at 60 °C as a colorless oil (87%): ^1^H NMR (250 MHz, CDCl~3~): δ 7.78, 7.45--7.42 (m, 2H), 6.98--6.95 (m, 2H), 4.31 (q, *J* = 7.1 Hz, 2H), 4.22 (q, *J* = 7.1 Hz, 2H), 3.85 (s, 3H), 3.55 (s, 2H), 1.36 (t, *J* = 7.1 Hz, 3H), 1.30 (t, *J* = 7.2 Hz, 3H). ^13^C NMR (126 MHz, CDCl~3~): δ 167.0, 160.6, 153.8, 141.6, 131.6 (2C), 127.1, 123.6, 114.4 (2C), 86.3, 73.1, 62.0, 61.4, 55.5, 18.3, 14.4, 14.1. IR (ATR, ν~max~): 2982, 2235, 1702, 1246, 828, 752. HRMS (ESI) *m*/*z* calcd for C~18~H~20~NaO~5~^+^ \[M + Na\]^+^, 339.1203; found, 339.1185.

### 1,6-Diethyl (5*E*)-5-\[(3,4,5-Trimethoxyphenyl)methylidene\]hex-2-ynedioate (**4af**) {#sec4.4.9}

It was obtained after 2 h at 60 °C as a pale yellow solid (88%): mp 49.0--50.2 °C. ^1^H NMR (500 MHz, CDCl~3~): δ 7.77 (s, 1H), 7.76 (s, 2H), 4.30 (q, *J* = 7.0 Hz, 2H), 4.19 (q, *J* = 7.0 Hz, 2H), 3.89--3.88 (m, 9H), 3.54 (s, 2H), 1.36 (t, *J* = 7.0 Hz, 3H), 1.27 (t, *J* = 7.0 Hz, 3H). ^13^C NMR (126 MHz, CDCl~3~): δ 166.6, 153.6, 153.4 (2C), 142.2, 139.0, 130.1, 125.0, 106.9 (2C), 86.1, 73.4, 62.0, 61.6, 61.0, 56.3 (2C), 18.5, 14.4, 14.1. IR (ATR, ν~max~): 2942, 2232, 1704, 1245, 1124, 857. HRMS (ESI) *m*/*z* calcd for C~20~H~24~NaO~7~^+^ \[M + Na\]^+^, 399.1414; found, 399.1386.

### 1,6-Diethyl (5*E*)-5-\[(2*E*)-3-phenylprop-2-en-1-ylidene\]hex-2-ynedioate (**4ag**) {#sec4.4.10}

It was obtained after 2 h at 60 °C as yellow oil (49%): ^1^H NMR (250 MHz, CDCl~3~): δ 7.54--7.32 (m, 6H), 7.16--6.94 (m, 2H), 4.28 (q, *J* = 7.1 Hz, 2H), 4.19 (q, *J* = 7.1 Hz, 2H), 3.57 (s, 2H), 1.35 (t, *J* = 7.1 Hz, 3H), 1.27 (t, *J* = 7.1 Hz, 3H). ^13^C NMR (63 MHz, CDCl~3~): δ 166.6, 153.8, 142.1, 141.1, 136.2, 129.5, 129.0 (2C), 127.6 (2C), 123.9, 122.9, 85.9, 73.1, 62.0, 61.3, 17.0, 14.4, 14.1. IR (ATR, ν~max~): 2983, 2237, 1706, 1251, 750. HRMS (ESI) *m*/*z* calcd for C~19~H~20~NaO~4~^+^ \[M + Na\]^+^, 335.1254; found, 335.1248.

### 1,6-Diethyl (5*E*)-5-propylidenehex-2-ynedioate (**4ah**) {#sec4.4.11}

It was obtained after 2 h at 60 °C as colorless oil (73%): ^1^H NMR (500 MHz, CDCl~3~): δ 6.91 (t, *J* = 7.5 Hz, 1H), 4.23 (q, *J* = 7.1 Hz, 2H), 4.20 (q, *J* = 7.1 Hz, 2H), 3.37 (s, 1H), 2.29 (quint, *J* = 7.5 Hz, 2H), 1.31 (t, *J* = 7.1 Hz, 3H), 1.29 (t, *J* = 7.5 Hz, 3H), 1.10 (t, *J* = 7.5 Hz). ^13^C NMR (126 MHz, CDCl~3~): δ 166.0, 153.5, 147.2, 125.2, 85.8, 72.5, 61.7, 60.9, 22.3, 16.3, 14.1, 13.9, 12.7. IR (ATR, ν~max~): 2980, 2236, 1706, 1247, 1074, 754. HRMS (ESI) *m*/*z* calcd for C~13~H~18~NaO~4~^+^ \[M + Na\]^+^, 261.1097; found, 261.1075.

### 1-Ethyl 6-Methyl (5*E*)-5-(phenylmethylidene)hex-2-ynedioate (**4ai**) {#sec4.4.12}

It was obtained after 2 h at 60 °C as colorless oil (72%): ^1^H NMR (400 MHz, CDCl~3~): δ 7.84 (s, 1H), 7.44--7.37 (m, 5H), 4.22 (q, *J* = 7.1 Hz, 2H), 3.96 (s, 3H), 3.52 (s, 2H), 1.30 (t, *J* = 7.1 Hz, 3H). ^13^C NMR (101 MHz, CDCl~3~): δ 167.1, 153.8, 142.2, 134.6, 129.6 (2C), 129.5, 128.9 (2C), 125.6, 85.9, 73.3, 62.0, 52.6, 18.3, 14.1. IR (ATR, ν~max~): 2985, 2236, 1704, 1247, 752. HRMS (ESI) *m*/*z* calcd for C~16~H~16~NaO~4~^+^ \[M + Na\]^+^, 295.0941; found, 295.0936.

### 1-Ethyl 6-Methyl (5*E*)-5-(Cyclohexylmethylidene)hex-2-ynedioate (**4aj**) {#sec4.4.13}

It was obtained after 2 h at 60 °C as yellow oil (72%): ^1^H NMR (250 MHz, CDCl~3~): δ 6.74 (d, *J* = 10 Hz, 1H), 4.19 (q, *J* = 7.1 Hz, 2H), 3.76 (s, 3H), 3.36 (s, 2H), 2.45--2.33 (m, 1H), 1.77--1.66 (m, 5H), 1.40--1.09 (m, 8H). ^13^C NMR (63 MHz, CDCl~3~): δ 167.1, 153.8, 151.1, 123.6, 86.3, 72.7, 61.9, 52.2, 38.4, 31.8 (2C), 25.8 (2C), 25.5, 16.7, 14.1. IR (ATR, ν~max~): 2931, 2854, 1712, 1250, 751. HRMS (ESI) *m*/*z* calcd for C~16~H~22~NaO~4~^+^ \[M + Na\]^+^, 301.1410; found, 301.1380.

### 1-Ethyl 6-Methyl (5*E*)-5-\[(1,1′-Biphenyl)-4-ylmethylidene\]hex-2-ynedioate (**4ak**) {#sec4.4.14}

It was obtained after 2 h at 60 °C as pale yellow oil (70%): ^1^H NMR (250 MHz, CDCl~3~): δ 7.88 (br s, 1H), 7.70--7.60 (m, 4H), 7.55--7.30 (m, 5H), 4.23 (q, *J* = 7.1 Hz, 2H), 3.88 (s, 3H), 3.59 (s, 2H), 1.31 (t, *J* = 7.1 Hz, 3H). ^13^C NMR (63 MHz, CDCl~3~): δ 167.2, 153.8, 142.3, 141.8, 140.2, 133.4, 130.2 (2C), 129.1 (2C), 128.0, 127.5 (2C), 127.2 (2C), 125.4, 85.9, 73.3, 62.1, 52.6, 18.4, 14.2.IR (ATR, ν~max~): 2951, 1743, 1715, 1247, 750. HRMS (ESI) *m*/*z* calcd for C~22~H~21~O~4~^+^ \[M + H\]^+^, 349.1435; found, 349.1431.

### 1-Ethyl 6-Methyl (5*E*)-5-\[(2*H*-1,3-Benzodioxol-5-yl)methylidene\]hex-2-ynedioate (**4al**) {#sec4.4.15}

It was obtained after 2 h at 60 °C as a pale yellow solid (79%): mp 80.9--83.7 °C. ^1^H NMR (250 MHz, CDCl~3~): δ 7.73 (s, 1H), 7.00--6.96 (m, 2H), 6.86 (d, *J* = 7.9 Hz, 1H), 6.02 (s, 2H), 4.24 (q, *J* = 7.1 Hz, 2H), 3.85 (s, 3H), 3.53 (s, 2H), 1.30 (t, *J* = 7.1 Hz, 3H). ^13^C NMR (63 MHz, CDCl~3~): δ 167.3, 153.8, 148.8, 148.2, 141.9, 128.5, 124.9, 123.8, 109.57, 108.8, 101.7, 85.8, 73.3, 62.0, 52.6, 18.3, 14.1. IR (ATR, ν~max~): 2995, 1743, 1714, 1236, 1036, 813. HRMS (ESI) *m*/*z* calcd for C~17~H~16~NaO~6~^+^ \[M + Na\]^+^, 339.0839; found, 339.0868.

### 1-Ethyl 6-Methyl (5*E*)-5-\[(furan-2-yl)methylidene\]hex-2-ynedioate (**4am**) {#sec4.4.16}

It was obtained after 2 h at 60 °C as yellow oil (69%): ^1^H NMR (250 MHz, CDCl~3~): δ 7.60 (d, *J* = 1.8 Hz, 1H), 7.51 (s, 1H), 6.74 (d, *J* = 3.5 Hz, 1H), 6.53 (dd, *J* = 3.5 Hz, 1.8 Hz, 1H), 4.18 (q, *J* = 7.2 Hz, 2H), 3.84--3.82 (m, 5H), 1.28 (t, *J* = 7.2 Hz, 3H). ^13^C NMR (126 MHz, CDCl~3~): δ 167.4, 153.9, 150.5, 145.6, 127.9, 120.9, 117.5, 112.5, 86.2, 72.5, 62.0, 52.6, 18.0, 14.2. IR (ATR, ν~max~): 2982, 2235, 1704, 1247, 1201, 725. HRMS (ESI) *m*/*z* calcd for C~14~H~14~NaO~5~^+^ \[M + Na\]^+^, 285.0733; found, 285.0716.

### Ethyl (5*E*)-6-Oxo-5-\[(3,4,5-trimethoxyphenyl)methylidene\]hept-2-ynoate (**4an**) {#sec4.4.17}

It was obtained after 2 h at 60 °C as a yellow solid (80%): mp 92.7--94.3 °C. ^1^H NMR (250 MHz, CDCl~3~): δ 7.60 (s, 1H), 6.80 (s, 2H), 4.18 (q, *J* = 7.1 Hz, 2H), 390--3.89 (m, 9H), 3.52 (s, 2H), 2.48 (s, 3H), 1.26 (t, *J* = 7.1 Hz, 3H). ^13^C NMR (63 MHz, CDCl~3~): δ 197.5, 153.5 (2C), 143.1, 139.4, 134.2, 130.0, 107.1 (2C), 86.4, 73.2, 62.0, 61.1, 56.4 (2C), 25.8, 17.1, 14.1. IR (ATR, ν~max~): 2995, 2233, 1708, 1251, 1126, 752. HRMS (ESI) *m*/*z* calcd for C~19~H~22~NaO~6~^+^ \[M + Na\]^+^, 366.1309; found, 369.1290.

### 6-*tert*-Butyl 1-Ethyl (5*E*)-5-(Phenylmethylidene)hex-2-ynedioate (**4ao**) {#sec4.4.18}

It was obtained after 2 h at 60 °C as colorless oil (60%): ^1^H NMR (250 MHz, CDCl~3~): δ 7.93 (br s, 1H), 7.61--7.46 (m, 5H), 4.41 (q, *J* = 7.1 Hz, 2H), 3.66 (s, 2H), 1.76 (s, 9H), 1.49 (t, *J* = 7.1 Hz, 3H). ^13^C NMR (63 MHz, CDCl~3~): δ 165.7, 153.8, 140.9, 134.9, 129.4 (2C), 129.1, 128.8 (2C), 127.4, 86.3, 81.8, 73.1, 61.9, 28.2 (3C), 18.4, 14.1. IR (ATR, ν~max~): 2978, 2235, 1704, 1247, 1158, 752. HRMS (ESI) *m*/*z* calcd for C~19~H~22~NaO~4~^+^ \[M + Na\]^+^, 337.1410; found, 337.1416.

### 6-*tert*-Butyl 1-Ethyl (5*E*)-5-\[(4-Methoxyphenyl)methylidene\]hex-2-ynedioate (**4ap**) {#sec4.4.19}

It was obtained after 2 h at 60 °C as colorless oil (85%): ^1^H NMR (250 MHz, CDCl~3~): δ 7.68 (br s, 1H), 7.42--7.36 (m, 2H), 6.97--6.91 (m, 2H), 4.21 (q, *J* = 7.1 Hz, 2H), 3.83 (s, 3H), 3.49 (s, 2H), 1.55 (s, 9H), 1.29 (t, *J* = 7.1 Hz, 3H). ^13^C NMR (63 MHz, CDCl~3~): δ 165.9, 160.2, 153.7, 140.5, 131.2 (2C), 127.2, 125.0, 114.2 (2C), 86.4, 81.4, 72.8, 61.8, 55.3, 28.1, 18.2, 14.0. IR (ATR, ν~max~): 2978, 2235, 1704, 1246, 1154, 752. HRMS (ESI) *m*/*z* calcd for C~20~H~24~NaO~5~^+^ \[M + Na\]^+^, 367.1516; found, 367.1500.

### Ethyl (5*E*)-5-Methyl-6-phenylhex-5-en-ynoate (**7**) {#sec4.4.20}

Enyne **7** was prepared according to a literature procedure:^[@ref33]^ to an oven-dried nitrogen purged flask containing a stir bar, *E*-(2-methyl-pent-1-en-4-ynyl)-benzene (6.4 mmol) and dry THF (10.5 mL) were added. The system was cooled to −78 °C using a dry ice-acetone cold bath. Then *n*-butyllithium (2.92 mL of 2.3 M in hexanes, 1.05 equiv) was added dropwise to the solution and stirred for 30 min. Next, freshly distilled ethyl chloroformate (0.396 mL, 4.02 mmol, 1.0 equiv) was added dropwise. The reaction temperature was held at −78 °C for 6 h and allowed to warm to room temperature overnight. The reaction was quenched with saturated aqueous ammonium chloride (30 mL) and extracted with CH~2~Cl~2~ (3 × 10 mL). After removal of solvent under reduced pressure, the residue was purified by flash silica gel column chromatography using a gradient mixture of ethyl acetate/hexane as eluent to afford the desired product **7** as pale yellow oil, 51% (68% brsm). ^1^H NMR (250 MHz, CDCl~3~): δ 7.37--7.20 (m, 5H), 6.54 (br s, 1H), 4.25 (q, *J* = 7.1 Hz, 2H), 3.22 (d, *J* = 1.0 Hz, 2H), 1.94 (d, *J* = 1.2 Hz, 3H), 1.33 (t, *J* = 7.1 Hz, 3H). ^13^C NMR (63 MHz, CDCl~3~): δ 153.9, 137.5, 131.2, 128.9 (2C), 128.2 (2C), 127.7, 126.7, 86.0, 75.5, 62.0, 29.6, 17.9, 14.2. IR (ATR, ν~max~): 2988, 2235, 1706, 1246, 1069, 752. HRMS (ESI) *m*/*z* calcd for C~15~H~17~O~2~^+^ \[M + H\]^+^, 229.1223; found, 229.1237.

General Procedure for the Synthesis of Hydrated Products (**5aa--ap**, **6a,6b**) {#sec4.5}
---------------------------------------------------------------------------------

In a 10 mL round-bottom flask containing a stir bar, enyne **4aa--ap** (0.2 mmol), chloro(triethylphosphine)gold(I) (0.01 equiv), silver triflate (0.02 equiv), acetonitrile (0.33 mL), and distilled water (0.17 mL) were added. The reaction mixture was stirred at 50 °C for 3 h. After reaction time, the solvent was removed under reduced pressure. The residue was purified by flash silica gel column chromatography using a gradient mixture of ethyl acetate/hexane as eluent to afford the corresponding product.

### 1,6-Diethyl (2*E*)-2-Methoxyphenylmethylidene-4-oxohexanedioate (**5aa**) {#sec4.5.1}

It was obtained as colorless oil (93%): ^1^H NMR (400 MHz, CDCl~3~): δ 7.94 (s, 1H), 7.40--7.30 (m, 5H), 4.22 (q, *J* = 7.1 Hz, 2H), 4.18 (q, *J* = 7.1 Hz, 2H), 3.72 (s, 2H), 3.57 (s, 2H), 1.32 (t, *J* = 7.1 Hz, 3H), 1.25 (t, *J* = 7.1 Hz, 3H). ^13^C NMR (101 MHz, CDCl~3~): δ 200.4, 167.3, 167.1, 142.7, 135.0, 129.1, 128.9 (2C), 128.8 (2C), 126.3, 61.5, 61.4, 49.62, 42.0, 14.3, 14.2. IR (ATR, ν~max~): 2982, 1745, 1704, 1260, 1026, 514. HRMS (ESI) *m*/*z* calcd for C~17~H~20~NaO~5~^+^ \[M + Na\]^+^, 327.1203; found, 327.1208.

### 1-Ethyl 6-Methyl (2*E*)-4-Oxo-2-(phenylmethylidene)hexanedioate (**5ba**) {#sec4.5.2}

It was obtained as colorless oil (90%): ^1^H NMR (400 MHz, CDCl~3~): δ 7.95 (s, 1H), 7.41--7.31 (m, 5H), 4.26 (q, *J* = 7.1 Hz, 2H), 3.73 (s, 3H), 3.72 (s, 2H), 3.60 (s, 2H), 1.33 (t, *J* = 7.1 Hz, 3H). ^13^C NMR (101 MHz, CDCl~3~): δ 200.3, 167.5, 167.3, 142.8, 135.0, 129.1, 128.9 (2C), 128.8 (2C), 126.3, 61.4, 52.5, 49.3, 42.0, 14.3. IR (ATR, ν~max~): 2983, 1748, 1702, 1262, 1203, 514. HRMS (ESI) *m*/*z* calcd for C~16~H~18~NaO~5~^+^ \[M + Na\]^+^, 313.1046; found, 313.1055.

### 6-*tert*-Butyl 1-Ethyl (2*E*)-4-Oxo-2-(phenylmethylidene)hexanedioate (**5ca**) {#sec4.5.3}

It was obtained as colorless oil (94%): ^1^H NMR (250 MHz, CDCl~3~): δ 7.94 (s, 1H), 7.42--7.29 (m, 5H), 4.25 (q, *J* = 7.1 Hz, 2H), 3.72 (s, 2H), 3.48 (s, 2H), 1.45 (s, 9H), 1.33 (t, *J* = 7.1 Hz, 3H). ^13^C NMR (63 MHz, CDCl~3~): δ 200.9, 167.3, 166.3, 142.6, 135.1, 129.0 (2C), 129.0, 128.7 (2C), 126.5, 82.1, 61.4, 51.0, 41.9, 28.1, 14.3. IR (ATR, ν~max~): 2981, 1714, 1264, 1142, 763. HRMS (ESI) *m*/*z* calcd for C~19~H~24~NaO~5~^+^ \[M + Na\]^+^, 355.1516; found, 355.1467.

### Ethyl (2*E*)-4,6-Dioxo-2-(phenylmethylidene)heptanoate (**5da**) {#sec4.5.4}

It was obtained as colorless oil (91%): (keto form/enol form = 2:3.5) ^1^H NMR (250 MHz, CDCl~3~) (enol form): δ 15.34 (br s, 1H), 7.95 (br s, 1H), 7.40--7.29 (m, 5H), 5.57 (s, 1H), 4.28 (q, *J* = 7.1 Hz, 2H), 3.57 (s, 2H), 2.04 (s, 3H), 1.33 (t, *J* = 7.1 Hz, 3H). (keto form): δ 7.98 (br s, 1H), 4.26 (q, *J* = 7.1 Hz, 2H), 3.70--3.68 (m, 4H), 2.26 (s, 3H). ^13^C NMR (126 MHz, CDCl~3~) (enol form): δ 194.8, 188.03 167.6, 142.5, 135.1, 129.3 (2C), 129.1, 128.8 (2C), 126.8, 99.6, 61.4, 38.1, 24.0, 14.3. IR (ATR, ν~max~): 2978, 1706, 1620, 1219, 1094, 706. HRMS (ESI) *m*/*z* calcd for C~16~H~18~NaO~4~^+^ \[M + Na\]^+^, 297.1097; found, 297.1074.

### 1,6-Diethyl (2*E*)-2-\[(4-Bromophenyl)methylidene\]-4-oxohexanedioate (**5ab**) {#sec4.5.5}

It was obtained as colorless oil (92%): ^1^H NMR (500 MHz, CDCl~3~): δ 7.86 (s, 1H), 7.52--7.50 (m, 2H), 7.21--7.19 (m, 2H), 4.26 (q, *J* = 7.1 Hz, 2H), 4.19 (q, *J* = 7.1 Hz, 2H), 3.69 (s, 2H), 3.58 (s, 2H), 1.33 (t, *J* = 7.1 Hz, 3H) 1.27 (s, *J* = 7.1 Hz, 3H). ^13^C NMR (126 MHz, CDCl~3~): δ 200.4, 167.1, 167.0, 141.5, 133.9, 132.0 (2C), 130.5 (2), 127.0, 123.5, 61.6, 61.6, 49.7, 42.0, 14.3, 14.2. IR (ATR, ν~max~): 2980, 1748, 1702, 1260, 1028, 510. HRMS (ESI) *m*/*z* calcd for C~17~H~19~BrNaO~5~^+^ \[M + Na\]^+^, 405.0308; found, 405.0330.

### 1,6-Diethyl (2*E*)-2-\[(4-Chlorophenyl)methylidene\]-4-oxohexanedioate (**5ac**) {#sec4.5.6}

It was obtained as colorless oil (93%): ^1^H NMR (400 MHz, CDCl~3~): δ 7.88 (s, 1H), 7.36--7.30 (m, 2H), 7.27--7.25 (m, 2H), 4.25 (q, *J* = 7.1 Hz, 2H), 4.19 (q, *J* = 7.1 Hz, 2H), 3.70 (s, 2H), 3.58 (s, 2H), 1.32 (t, *J* = 7.1 Hz, 3H), 1.26 (t, *J* = 7.1 Hz, 3H). ^13^C NMR (101 MHz, CDCl~3~): δ 200.4, 167.1, 167.0, 141.4, 135.2, 133.4, 130.7, 130.3 (2C), 129.0 (2C), 126.9, 61.6, 61.5, 49.6, 41.9, 14.3, 14.2. IR (ATR, ν~max~): 2983, 1743, 1704, 1015, 514. HRMS (ESI) *m*/*z* calcd for C~17~H~19~ClNaO~5~^+^ \[M + Na\]^+^, 361.0813; found, 361.0821.

### 1,6-Diethyl (2*E*)-2-\[(3-Chlorophenyl)methylidene\]-4-oxohexanedioate (**5ad**) {#sec4.5.7}

It was obtained as colorless oil (91%): ^1^H NMR (500 MHz, CDCl~3~): δ 7.86 (s, 1H), 7.32--7.20 (m, 4H), 4.26 (q, *J* = 7.1 Hz, 2H) 4.19 (q, *J* = 7.1 Hz, 2H) 3.70 (s, 2H), 3.58 (s, 2H), 1.33 (t, *J* = 7.1 Hz, 3H), 1.26 (t, *J* = 7.1 Hz, 3H). ^13^C NMR (101 MHz, CDCl~3~): δ 200.2, 167.0, 166.9, 141.1, 136.9, 134.7, 130.1, 129.1, 128.8, 127.7, 126.9, 61.7, 61.6, 49.7, 41.9, 14.3, 14.2. IR (ATR, ν~max~): 2982, 1745, 1704, 1089, 789. HRMS (ESI) *m*/*z* calcd for C~17~H~19~ClNaO~5~^+^ \[M + Na\]^+^, 361.0813; found, 361.0819.

### 1,6-Diethyl (2*E*)-2-\[(4-Methoxyphenyl)methylidene\]-4-oxohexanedioate (**5ae**) {#sec4.5.8}

It was obtained as colorless oil (95%): ^1^H NMR (400 MHz, CDCl~3~): δ 7.89 (s, 1H), 7.32--7.28 (m, 2H), 6.92--6.88 (m, 2H), 4.24 (q, *J* = 7.1 Hz, 2H), 4.18 (q, *J* = 7.1 Hz, 2H), 3.82 (s, 3H), 3.75 (s, 2H), 3.58 (s, 2H), 1.32 (t, *J* = 7.1 Hz, 3H) 1.26 (s, *J* = 7.1 Hz, 3H). ^13^C NMR (101 MHz, CDCl~3~): δ 200.6, 167.5, 167.1, 160.3, 142.4, 130.8 (2C), 127.3, 123.9, 114.1 (2C), 61.4, 61.1, 55.3, 49.4, 42.0, 14.2, 14.1. IR (ATR, ν~max~): 2983, 1743, 1698, 1028, 752, 534. HRMS (ESI) *m*/*z* calcd for C~18~H~22~NaO~6~^+^ \[M + Na\]^+^, 357.1309; found, 357.1313.

### 1,6-Diethyl (2*E*)-4-Oxo-2-\[(3,4,5-trimethoxyphenyl)methylidene\]hexanedioate (**5af**) {#sec4.5.9}

It was obtained as pale yellow oil (93%): ^1^H NMR (250 MHz, CDCl~3~): δ 7.89 (s, 1H), 6.61 (s, 2H), 4.26 (q, *J* = 7.1 Hz, 2H), 4.27 (q, *J* = 7.1 Hz, 2H), 3.91--3.80 (m, 9H), 3.75 (s, 2H), 3.60 (s, 2H), 1.34 (t, *J* = 7.1 Hz, 3H), 1.25 (t, *J* = 7.1 Hz, 3H). ^13^C NMR (63 MHz, CDCl~3~): δ 201.2, 167.3, 167.2, 153.4 (2C), 143.2, 138.9, 130.4, 125.6, 106.2 (2C), 61.6, 61.5, 61.0, 56.3, 49.6, 42.4, 14.4, 14.2. IR (ATR, ν~max~): 2975, 1745, 1715, 1258, 1126. HRMS (ESI) *m*/*z* calcd for C~20~H~26~NaO~8~^+^ \[M + Na\]^+^, 417.1520; found, 417.1537.

### 1,6-Diethyl (2*E*)-4-Oxo-2-\[(2*E*)-3-phenylprop-2-en-1-ylidene\]hexanedioate (**5ag**) {#sec4.5.10}

It was obtained as yellow oil (94%): ^1^H NMR (250 MHz, CDCl~3~): δ 7.59--7.46 (m, 3H), 7.38--7.30 (m, 3H), 6.98--6.96 (m, 2H), 4.23 (q, *J* = 7.1 Hz, 2H), 4.21 (q, *J* = 7.1 Hz, 2H), 3.75 (s, 2H), 3.56 (s, 2H), 1.32 (t, *J* = 7.1 Hz, 3H), 1.27 (t, *J* = 7.1 Hz, 3H). ^13^C NMR (63 MHz, CDCl3): δ ^13^C NMR (63 MHz, CDCl~3~): δ 199.7, 167.4, 167.3, 142.1, 141.8, 136.2, 129.3, 128.9 (2C), 127.5 (2C), 123.9, 123.2, 61.6, 61.2, 48.8, 41.5, 14.4, 14.2. IR (ATR, ν~max~): 2985, 1745, 1718, 1697, 1238, 750. HRMS (ESI) *m*/*z* calcd for C~19~H~22~NaO~5~^+^ \[M + Na\]^+^, 353.1359; found, 353.1341.

### 1,6-Diethyl (2*E*)-4-Oxo-2-propylidenehexanedioate (**5ah**) {#sec4.5.11}

It was obtained as colorless oil (95%): ^1^H NMR (400 MHz, CDCl~3~): δ 6.99 (t, *J* = 7.5 Hz, 1H), 4.18 (quint, *J* = 7.1 Hz, 4H), 3.53 (s, 2H), 3.50 (s, 2H), 2.16 (quint, *J* = 7.5 Hz, 2H), 1.27 (t, *J* = 7.1 Hz, 6H), 1.05 (t, *J* = 7.5 Hz, H). ^13^C NMR (101 MHz, CDCl~3~): δ 199.7, 167.3, 167.0, 148.1, 124.9, 61.5, 61.0, 49.0, 40.9, 22.5, 14.3, 14.2, 13.1. IR (ATR, ν~max~): 2978, 1745, 1704, 1249, 1028. HRMS (ESI) *m*/*z* calcd for C~13~H~20~NaO~5~^+^ \[M + Na\]^+^, 279.1203; found, 279.1208.

### 6-Ethyl 1-Methyl (2*E*)-4-oxo-2-(phenylmethylidene)hexanedioate (**5ai**) {#sec4.5.12}

It was obtained as colorless oil (92%): ^1^H NMR (400 MHz, CDCl~3~): δ 7.95 (s, 1H), 7.40--7.30 (m, 5H), 4.19 (q, *J* = 7.1 Hz, 2H), 3.80 (s, 3H), 3.74 (s, 2H), 3.57 (s, 2H), 1.26 (t, *J* = 7.1 Hz, 3H). ^13^C NMR (101 MHz, CDCl~3~): δ 200.4, 167.8, 167.1, 143.0, 135.0, 129.2, 129.0 (2C), 128.8 (2C), 126.0, 61.6, 52.4, 49.6, 42.0, 14.2. IR (ATR, ν~max~): 2985, 1743, 1707, 1264, 1205, 512. HRMS (ESI) *m*/*z* calcd for C~16~H~18~NaO~5~^+^ \[M + Na\]^+^, 313.1046; found, 313.1046.

### 6-Ethyl 1-Methyl (2*E*)-2-(Cyclohexylmethylidene)-4-oxohexanedioate (**5aj**) {#sec4.5.13}

It was obtained as colorless oil (93%): ^1^H NMR (250 MHz, CDCl~3~): δ 6.83 (d, *J* = 10.1 Hz, 1H), 4.20 (q, *J* = 7.1 Hz, 2H), 3.72 (s, 3H), 3.54--3.53 (m, 4H), 2.27--2.19 (m, 1H), 1.71--1.56 (m, 5H), 1.36--1.10 (m, 8H). ^13^C NMR (63 MHz, CDCl~3~): δ 199.9, 167.8, 167.3, 151.7, 123.3, 61.5, 52.1, 49.2, 41.1, 38.4, 32.0 (2C), 25.9, 25.5 (2C), 14.3. IR (ATR, ν~max~): 2927, 2852, 1747, 1717, 1226. HRMS (ESI) *m*/*z* calcd for C~16~H~24~NaO~5~^+^ \[M + Na\]^+^, 319.1516; found, 319.1499.

### 6-Ethyl 1-Methyl (2*E*)-2-\[(1,1′-Biphenyl)-4-ylmethylidene\]-4-oxohexanedioate (**5ak**) {#sec4.5.14}

It was obtained as colorless oil (93%): ^1^H NMR (250 MHz, CDCl~3~): δ 8.01 (br s, 1H), 7.70--7.60 (m, 4H), 7.55--7.35 (m, 5H), 4.23 (q, *J* = 7.1 Hz, 2H), 3.84 (m, 5H), 3.63 (s, 2H), 1.29 (t, *J* = 7.1 Hz, 3H). ^13^C NMR (63 MHz, CDCl~3~): δ 200.4, 167.8, 167.1, 142.6, 142.0, 140.3, 133.8, 129.6 (2C), 129.0 (2C), 127.9, 127.4 (2C), 127.2 (2C), 125.8, 61.6, 52.5, 49.6, 42.2, 14.2.^.^ IR (ATR, ν~max~): 2966, 1742, 1256, 1217, 753. HRMS (ESI) *m*/*z* calcd for C~22~H~22~NaO~5~^+^ \[M + Na\]^+^, 389.1360; found, 389.1349.

### 6-Ethyl 1-Methyl (2*E*)-2-\[(2*H*-1,3-Benzodioxol-5-yl)methylidene\]-4-oxohexanedioate (**5al**) {#sec4.5.15}

It was obtained as yellow oil (95%): ^1^H NMR (250 MHz, CDCl~3~): δ 7.58 (br s, 1H), 7.52 (d, *J* = 1.8 Hz, 1H), 6.66 (d, *J* = 3.5 Hz, 1H), 6.48 (dd, *J* = 1.8 Hz, 3.5 Hz, 1H), 4.21 (q, *J* = 7.1 Hz, 2H), 4.05 (s, 2H), 3.79 (s, 3H), 3.53 (s, 2H), 1.28 (t, *J* = 7.1 Hz, 3H). ^13^C NMR (63 MHz, CDCl~3~): δ 199.7, 168.1, 167.2, 151.0, 145.2, 128.5, 120.9, 117.3, 112.4, 61.5, 52.5, 49.2, 42.4, 14.2. IR (ATR, ν~max~): 2963, 1749, 1720, 1286, 1215, 753. HRMS (ESI) *m*/*z* calcd for C~17~H~18~NaO~7~^+^ \[M + Na\]^+^, 357.0945; found, 357.0931.

### 6-Ethyl 1-Methyl (2*E*)-2-\[(Furan-2-yl)methylidene\]-4-oxohexanedioate (**5am**) {#sec4.5.16}

It was obtained as yellow oil (95%): ^1^H NMR (250 MHz, CDCl~3~): δ 7.58 (br s, 1H), 7.52 (d, *J* = 1.8 Hz, 1H), 6.66 (d, *J* = 3.5 Hz, 1H), 6.48 (dd, *J* = 1.8 Hz, 3.5 Hz, 1H), 4.21 (q, *J* = 7.1 Hz, 2H), 4.05 (s, 2H), 3.79 (s, 3H), 3.53 (s, 2H), 1.28 (t, *J* = 7.1 Hz, 3H). ^13^C NMR (63 MHz, CDCl~3~): δ 199.7, 168.1, 167.2, 151.0, 145.2, 128.5, 120.9, 117.3, 112.4, 61.5, 52.5, 49.2, 42.4, 14.2. IR (ATR, ν~max~): 2963, 1749, 1720, 1286, 1215, 753. HRMS (ESI) *m*/*z* calcd for C~14~H~16~NaO~6~^+^ \[M + Na\]^+^, 303.0839; found, 303.0852.

### Ethyl (5*E*)-3,6-Dioxo-5-\[(3,4,5-trimethoxyphenyl)methylidene\]heptanoate (**5an**) {#sec4.5.17}

It was obtained as yellow oil (92%): ^1^H NMR (250 MHz, CDCl~3~): δ 7.72 (br s, 1H), 6.64 (br s, 2H), 4.17 (q, *J* = 7.1 Hz, 2H), 3.88--6.86 (m, 9H), 3.70 (s, 2H), 3.62 (s, 2H), 2.46 (s, 3H), 1.25 (t, *J* = 7.1 Hz, 3H). ^13^C NMR (63 MHz, CDCl~3~): δ 201.4, 199.0, 167.3, 153.5, 144.1, 139.1, 135.6, 130.4, 106.3, 61.5, 61.1, 56.3, 41.3, 25.4, 14.2. IR (ATR, ν~max~): 2987, 1742, 1716, 1334, 1112. HRMS (ESI) *m*/*z* calcd for C~19~H~24~NaO~7~^+^ \[M + Na\]^+^, 387.1414; found, 387.1442.

### Ethyl 2-\[(2*Z*,4*E*)-5-Oxo-4-(phenylmethylidene)oxolan-2-ylidene\]acetate (**6a′**) {#sec4.5.18}

It was obtained after filtration on a plug of Celite as a yellow solid (\>99%): mp 171.6--173.2 °C. ^1^H NMR (250 MHz, CDCl~3~): δ 7.69 (t, *J* = 2.8 Hz, 1H), 7.51--7.45 (m, 5H), 5.26 (t, *J* = 1.6 Hz, 1H), 4.23 (q, *J* = 7.1 Hz, 2H), 9.93 (dd, *J* = 2.8 Hz, 1.6 Hz), 1.31 (t, *J* = 7.1 Hz, 3H). ^13^C NMR (63 MHz, CDCl~3~): δ 168.8, 163.9, 158.6, 139.3, 133.8, 131.0, 130.5 (2C), 129.3 (2C), 118.7, 96.5, 60.5, 32.7, 14.4. IR (ATR, ν~max~): 2983, 1795, 1709, 1151, 765. HRMS (ESI) *m*/*z* calcd for C~15~H~14~NaO~4~^+^ \[M + Na\]^+^, 281.0784; found, 281.1171.

### Ethyl 2-\[(4*E*)-5-Oxo-4-(phenylmethylidene)-4,5-dihydrofuran-2-yl\]acetate (**6a**) {#sec4.5.19}

It was obtained as yellow oil: (\>99%) ^1^H NMR (250 MHz, CDCl~3~): δ 7.58--7.54 (m, 2H), 7.47--7.39 (m, 4H), 6.56 (q, *J* = Hz, 1.1 Hz, 1H), 4.22 (q, *J* = 7.1 Hz, 2H), 3.53 (t, *J* = 1.1 Hz, 2H), 1.30 (t, *J* = 4.1 Hz, 3H). ^13^C NMR (151 MHz, CDCl~3~): δ 169.2, 167.6, 153.6, 136.3, 134.9, 130.5 (2C), 130.2, 129.2 (2C), 124.8, 104.4, 61.8, 34.9, 14.2. IR (ATR, ν~max~): 2980, 1769, 1734, 1158, 763HRMS (ESI) *m*/*z* calcd for C~15~H~14~NaO~4~^+^ \[M + Na\]^+^, 281.0784; found, 281.0783.

### Ethyl2-\[(4*E*)-4-\[(4-Methoxyphenyl)methylidene\]-5-oxo-4,5-dihydrofuran-2-yl\]acetate (**6b**) {#sec4.5.20}

It was obtained as a yellow solid (90%): mp 153.9--156.0 °C. ^1^H NMR (250 MHz, CDCl~3~): δ 7.55--7.52 (m, 2H), 7.33 (br s, 1H), 6.96--6.92 (m, 2H), 6.54 (br s, 1H), 4.21 (q, *J* = 7.1 Hz, 2H), 3.86 (s, 3H), 3.52 (br s, 2H), 1.29 (t, *J* = 7.1 Hz, 3H). ^13^C NMR (63 MHz, CDCl~3~): δ 169.7, 167.8, 161.6, 152.5, 136.3, 132.2 (2C), 122.2, 114.8 (2C), 104.3, 61.8, 55.6, 34.9, 14.3. IR (ATR, ν~max~): 2924, 1776, 1715, 1151, 746. HRMS (ESI) *m*/*z* calcd for C~16~H~16~NaO~5~^+^ \[M + Na\]^+^, 311.0890; found, 311.0865.

### Ethyl (5*E*)-5-Methyl-3-oxo-6-phenylhex-5-enoate (**8**) {#sec4.5.21}

It was obtained as colorless oil, (49%) (77% brsm) (keto form/enol form = 7.7:1) ^1^H NMR (250 MHz, CDCl~3~) (keto form): δ 7.35--7.23 (m, 5H), 6.41 (br s, 1H), 4.20 (q, *J* = 7.1 Hz, 2H), 3.53 (s, 2H), 3.38 (d, *J* = 0.9 Hz, 2H), 1.90 (d, *J* = 1.3 Hz, 3H), 1.28 (t, *J* = 7.1 Hz, 3H). (enol form): δ 12.14 (s, 1H), 5.09 (s, 1H), 3.06 (s, 2H), 1.91 (d, *J* = 1.3 Hz, 3H), 1.30 (t, *J* = 7.1 Hz, 3H). ^13^C NMR (63 MHz, CDCl~3~): δ 201.1, 167.3, 137.5, 131.5, 130.5, 129.0 (2C), 128.3 (2C), 126.8, 61.6, 54.9, 48.4, 18.3, 14.2. IR (ATR, ν~max~): 2982, 1745, 1719, 1316, 1255, 704. HRMS (ESI) *m*/*z* calcd for C~15~H~18~NaO~3~^+^ \[M + Na\]^+^, 269.1148; found, 269.1147.

General Procedure for the Synthesis of Lactones (**9a--g**) {#sec4.6}
-----------------------------------------------------------

In a 10 mL round-bottom flask containing a stir bar was added ketone **5** (0.1 mmol), methanol (1.3 mL), and sodium borohydride (0.12 mmol, 1.2 equiv). The reaction mixture was stirred for 30 min at 0 °C. After complete consumption of the standard material, the reaction was quenched with H~2~O (10 mL) and extracted with ethyl acetate (3 × 10 mL) to afford pure lactones **9a--g**.

### Ethyl 2-\[(4*E*)-5-Oxo-4-(phenylmethylidene)oxolan-2-yl\]acetate (**9a**) {#sec4.6.1}

It was obtained as colorless oil (83%): ^1^H NMR (500 MHz, CDCl~3~): δ 7.58 (t, *J* = 2.7 Hz, 1H), 7.49--7.39 (m, 5H), 5.00 (dddd, *J* = 8.0, 7.3, 6.0, 5.3 Hz, 1H), 4.19 (q, *J* = 7.1 Hz, 2H), 3.48 (ddd, *J* = 17.7, 8.0, 2.7 Hz, 1H), 2.97 (ddd, *J* = 17.7, 5.3, 2.7 Hz, 1H), 2.89 (dd, *J* = 16.3 Hz, 6.0 Hz, 1H), 2.69 (dd, *J* = 16.3 Hz, 7.3 Hz, 1H), 1.27 (t, *J* = 7.1 Hz, 3H). ^13^C NMR (101 MHz, CDCl~3~): δ 171.6, 169.6, 137.3, 134.6, 130.2 (2C), 130.1, 129.1 (2C), 123.8, 73.4, 61.2, 40.9, 33.5, 14.3. IR (ATR, ν~max~): 2963, 1730, 1652, 1270, 1154, 514. HRMS (ESI) *m*/*z* calcd for C~15~H~17~O~4~^+^ \[M + H\]^+^, 261.1121; found, 261.1127.

### Ethyl 2-\[(4*E*)-4-\[(4-Methoxyphenyl)methylidene\]-5-oxolan-2-yl\]acetate (**9b**) {#sec4.6.2}

It was obtained as a pale yellow solid (75%): mp 84.5--86.2 °C. ^1^H NMR (500 MHz, CDCl~3~): δ 7.53 (t, *J* = 2.7 Hz, 1H), 7.46--7.44 (m, 2H), 6.96--6.95 (m, 2H), 5,00 (dddd, *J* = 8.2, 7.3, 6.0, 5.3 Hz, 1H), 4.18 (q, *J* = 7.1 Hz, 2H), 3.85 (s, 3H), 3.45 (ddd, *J* = 17.5, 8.2, 2.7 Hz, 1H), 2.92 (ddd, *J* = 17.5, 5.3, 2.7 Hz, 1H), 2.89 (dd, *J* = 16.3 Hz, 6.0 Hz, 1H), 2.62 (dd, *J* = 16.3 Hz, 7.3 Hz, 1H), 1.28 (t, *J* = 7.1 Hz, 3H). ^13^C NMR (126 MHz, CDCl~3~): δ 172.0, 169.7, 161.1, 137.0, 132.0 (2C), 127.4, 120.8, 114.6 (2C), 73.2, 61.1, 55.5, 40.9, 33.5, 14.2. IR 2967, 1726, 1650, 1259, 1171, 541. (ATR, ν~max~): 2 HRMS (ESI) *m*/*z* calcd for C~16~H~19~O~5~^+^ \[M + H\]^+^, 291.1227; found, 291.1220.

### Ethyl 2-\[(4*E*)-5-Oxo-4-\[(3,4,5-trimethoxyphenyl)methylidene\]oxolan-2-yl\]acetate (**9c**) {#sec4.6.3}

It was obtained as colorless oil (74%): ^1^H NMR (250 MHz, CDCl~3~): δ 7.50 (t, *J* = 2.9 Hz, 1H), 6.71 (s, 2H), 5.06--4.96 (m, 1H), 4.19 (q, *J* = 7.2 Hz, 2H), 3.90--3.89 (m, 9H), 3.48 (ddd, *J* = 17.5, 8.1, 2.9 Hz, 1H), 2.97 (ddd, *J* = 7.5, 5.3, 2.9 Hz, 1H), 2.89 (dd, *J* = 16.3 Hz, 5.9 Hz), 2.70 (dd, *J* = 16.3 hz, 7.1 Hz, 1H), 1.28 (t. *J* = 7.2 Hz, 3H). ^13^C NMR (126 MHz, CDCl~3~): δ 171.6, 169.6, 153.6, 140.2, 137.5, 130.1, 122.7, 107.7, 73.3, 61.2, 61.2, 56.4, 40.8, 33.3, 29.8, 14.3. IR (ATR, ν~max~): 2920, 2849, 1741, 1651, 1199, 1127. HRMS (ESI) *m*/*z* calcd for C~18~H~22~NaO~7~^+^ \[M + Na\]^+^, 373.1258; found, 273.1264.

### tert-Butyl 2-\[(4*E*)-5-Oxo-4-(phenylmethylidene)oxolan-2-yl\]acetate (**9d**) {#sec4.6.4}

It was obtained as colorless oil (78%): ^1^H NMR (250 MHz, CDCl~3~): δ 7.58 (t, *J* = 2.9 Hz, 1H), 7.52--7.40 (m, 5H), 4.96 (dddd, *J* = 8.1, 7.3, 5.8, 5.4 Hz, 1H), 3.46 (ddd, *J* = 17.7, 8.1, 2.9 Hz, 1H), 2.97 (ddd, *J* = 17.7, 5.4, 2.9 Hz, 1H), 2.82 (dd, *J* = 16.0 Hz, 5.8 Hz, 1H), 2.61 (dd, *J* = 16.0 Hz, 7.3 Hz, 1H), 1.47 (s, 9H). ^13^C NMR (63 MHz, CDCl~3~): δ 171.7, 168.9, 137.2, 134.7, 130.2 (2C), 130.1, 129.1 (2C), 124.0, 81.9, 73.6, 42.1, 33.5, 28.2 (3C). IR. (ATR, ν~max~): 2983, 1753, 1729, 1654, 1178, 1148. HRMS (ESI) *m*/*z* calcd for C~17~H~21~O~4~^+^ \[M + H\]^+^, 289.1434; found, 289.1407.

### Ethyl 2-\[(4*E*)-4-\[(Furan-2-yl)methylidene\]-5-oxooxolan-2-yl\]acetate (**9e**) {#sec4.6.5}

It was obtained as colorless oil (65%): ^1^H NMR (500 MHz, CDCl~3~): δ 7.58 (d, *J* = 1.7 Hz, 1H), 7.32 (t, *J* = 2.8 Hz, 1H), 6.67 (d, *J* = 3.4 Hz, 1H), 6.53 (dd, *J* = 3.4, 1.7 Hz, 1H), 5.01 (m, 1H), 4.19 (q, *J* = 7.1 Hz, 3H), 3.52 (ddd, *J* = 18.8, 8.2, 2.8 Hz, 1H), 2.98 (ddd, *J* = 18.8, 5.5, 2.8 Hz, 1H), 2.87 (dd, *J* = 16.2, 6.1 Hz, 1H), 2.68 (dd, *J* = 16.2, 7.0 Hz, 1H), 1.28 (t, *J* = 7.1 Hz, 3H). ^13^C NMR (126 MHz, CDCl~3~): δ 171.5, 169.7, 151.3, 145.5, 123.36, 121.3, 116.4, 112.7, 73.6, 61.2, 41.0, 33.4, 14.3. IR (ATR, ν~max~): 2959, 2923, 2852, 1753, 1656, 1259, 1182, 1039. HRMS (ESI) *m*/*z* calcd for C~13~H~14~NaO~5~^+^ \[M + Na\]^+^, 273.0733; found, 273.0756.

### Ethyl 2-\[(4*E*)-5-Oxo-4-\[(2*E*)-3-phenylprop-2-en-1-ylidene\]oxolan-2-yl\]acetate (**9f**) {#sec4.6.6}

It was obtained as colorless oil (73%): ^1^H NMR (500 MHz, CDCl~3~): δ 7.50--7.47 (m, 2H), 7.39--7.31 (m, 3H), 7.29--7.27 (m, 1H), 6.97 (d, *J* = 15.5 Hz, 1H), 6.81 (dd, *J* = 15.5 Hz, 11.5 Hz, 1H), 4.99 (dd, *J* = 8.2 Hz, *J* = 7.4 Hz, *J* = 5.9, 1H), 4.19 (q, *J* = 7.2 Hz, 2H), 3.33 (ddd, *J* = 17.8, 8.2, 2.7 Hz, 1H), 2.89 (dd, *J* = 16.2 Hz, 5.9 Hz, 1H), 2.81 (ddd, *J* = 17.8 Hz, 5.9 Hz, 2.7, 1H), 2.67 (dd, *J* = 16.2 Hz, 7.4 Hz, 1H), 1.29 (t, *J* = 7.2 Hz, 3H). ^13^C NMR (63 MHz, CDCl~3~): δ 171.0, 169.7, 142.0, 136.6, 136.0, 129.6, 129.0, 127.5, 124.5, 123.8, 73.4, 61.2, 40.9, 31.8, 14.3. IR (ATR, ν~max~): 2983, 1743, 1640, 1188, 1027. HRMS (ESI) *m*/*z* calcd for C~17~H~18~NaO~4~^+^ \[M + Na\]^+^, 309.1097; found, 309.1068.

The Supporting Information is available free of charge at [https://pubs.acs.org/doi/10.1021/acsomega.0c00101](https://pubs.acs.org/doi/10.1021/acsomega.0c00101?goto=supporting-info).Copies of ^1^H and ^13^C NMR spectra of all of the new compounds and copies of 2D NOESY, HSQC, and HMBC correlation maps for selected compounds ([PDF](http://pubs.acs.org/doi/suppl/10.1021/acsomega.0c00101/suppl_file/ao0c00101_si_001.pdf)).
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